Physician profile
David E Taylor
NPI 1487637104
$699.68
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $624 · 2020: $75.21.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $217.52 | 2019 | |
| Medtronic USA, INC. | $137.56 | 2019 | |
| Medical Device Business Services, INC. | $103.61 | 2019 | |
| Sun Pharmaceutical Industries INC. | $51.32 | 2020 | |
| Sanofi-Aventis U.S. LLC | $43.17 | 2019 | |
| Zyla Life Sciences, INC. | $39.94 | 2019 | |
| Ferring Pharmaceuticals INC. | $31.45 | 2019 | |
| Fidia Pharma USA INC. | $30.47 | 2019 | |
| Amgen INC. | $23.89 | 2020 | |
| Pacira Therapeutics, INC. | $20.75 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.